Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in PCD pharma franchise in Hyderabad

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in pharmaceutical manufacturing company in Mumbai

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in cardiac care pharma franchise in Pune

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in pharma suppliers in Delhi

Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in pharma export companies in Kolkata
Telmisartan 40mg + Cilnidipine 10mg + Metoprolol 50mg Tablet in pharma franchise opportunities in Bengaluru

Telbolife Trio 50 Tablet

Composition : Telmisartan IP 40mg + Cilnidipine IP 10mg + Metoprolol IP 50mg

Dosage Form : Tablet

Packaging Type : Alu ALu

Packaging : 10x15

Price : ₹395/-

Please Contact For Best Price

Telbolife Trio 50 Tablet is a triple-drug combination tablet formulated to provide comprehensive control of high blood pressure and reduce cardiovascular risk. It combines three proven classes of antihypertensive agents:

  • Telmisartan (an ARB) blocks angiotensin II receptors, reducing vasoconstriction and blood pressure.

  • Cilnidipine (a dual L/N-type calcium channel blocker) relaxes blood vessels and offers renal and vascular protection.

  • Metoprolol Succinate (a beta-1 selective blocker) lowers heart rate, cardiac workload, and provides cardioprotection.

This combination helps in managing resistant hypertension and reducing the risk of stroke, heart attack, and kidney complications associated with uncontrolled blood pressure.

Read More

About the Product

Telbolife Trio 50 Tablet is a triple-drug combination tablet formulated to provide comprehensive control of high blood pressure and reduce cardiovascular risk. It combines three proven classes of antihypertensive agents:

  • Telmisartan (an ARB) blocks angiotensin II receptors, reducing vasoconstriction and blood pressure.

  • Cilnidipine (a dual L/N-type calcium channel blocker) relaxes blood vessels and offers renal and vascular protection.

  • Metoprolol Succinate (a beta-1 selective blocker) lowers heart rate, cardiac workload, and provides cardioprotection.

This combination helps in managing resistant hypertension and reducing the risk of stroke, heart attack, and kidney complications associated with uncontrolled blood pressure.

Patients may experience mild side effects such as fatigue, dizziness, headache, slow heartbeat, or ankle swelling. In rare cases, hypotension, electrolyte imbalances, or bradycardia may occur. Serious adverse effects are uncommon but require immediate medical attention.

Telbolife Trio 50 Tablet is indicated for patients with essential hypertension who require multiple drugs to achieve target blood pressure levels. It is particularly beneficial in individuals with associated comorbidities like diabetes, chronic kidney disease, ischemic heart disease, or those at high cardiovascular risk. The combination offers synergistic antihypertensive action with organ protection and improved treatment adherence.

Use only under the supervision of a registered medical practitioner. Caution is advised in patients with liver, renal, or heart disorders. Regular monitoring of blood pressure, electrolytes, and cardiac function is recommended. Not advised during pregnancy or lactation unless directed by a physician.

Store below 25°C in a dry, cool place. Protect from direct light and moisture. Keep out of reach of children.

Get in Touch